Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05916690
Status:
RECRUITING
Last Update Posted:
2024-01-19
First Post:
2023-06-01
Brief Title:
Electrochemotherapy for the Treatment of Vulvar Cancer
Sponsor:
Institute of Oncology Ljubljana
Organization:
Institute of Oncology Ljubljana
Study Overview
Official Title:
Electrochemotherapy for the Treatment of Vulvar Cancer
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Electrochemotherapy is a local treatment modality with effectiveness comparable to other local ablation techniques With electrochemotherapy 80 objective response can be achieved and is suitable for the treatment of different types of tumors The method is based on increased drug delivery to cells previously exposed to electroporation The most commonly used cytotoxic agents are bleomycin and cisplatin The aim of the proposed clinical trial is to determine the efficacy feasibility and safety of electrochemotherapy in the treatment of vulvar cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None